๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adriamycin and 1-(2-Chlorethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU) in the treatment of metastatic breast cancer

โœ Scribed by William C. Waterfield; Charles K. Tashima; Gabriel N. Hortobagyi; George R. Blumenschein; Aman U. Buzdar; Michael A. Burgess


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
354 KB
Volume
41
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Physiologic disposition of 1-(2-chloroet
โœ Robert W. Sponzo; Vincent T. Devita; Vincent T. Oliverio ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 466 KB ๐Ÿ‘ 1 views

The physiologic disposition of radioactive-labelled CCNU and MeCCNU was studied in patients receiving these drugs as part of their early clinical trial. CCNU was given orally in doses of 30-100 mg/m2 a n d MeCCNU in doses of 120-290 mg/m?. With both drugs, significant plasma levels of radioactivity

Mutational specificity of 1-(2-chloroeth
โœ Francisco L. Luque-Romero; Raffaella Iannone; Alberto Inga; Gilberto Fronza; Car ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

Forward mutations induced by 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the supF gene of Escherichia coli were recovered from bacteria deficient in nucleotide excision repair and in DNA-alkyltransferase activity. Bacteria were exposed to 0.4 mM CCNU (in vivo supF mutagenesis), increasing